MGMT and glioblastoma: Comparing radiotherapy versus TMZ in elderly GBM patients, the NOA‐08 trial found the prognostic impact of MGMT promoter methylation status was limited to GBM of the RTK II subgroup and was absent in the RTK I and MES subgroups.